itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Effectiveness of cold application combined with progressive muscle relaxation in migraine without aura: A randomized controlled trial

    7 октября, 2025

    CONCLUSION: Both JPMR and JPMR combined with cold application are effective short-term interventions for managing migraine without aura. However, the addition of cold application enhances outcomes in the number of attacks. This combined nonpharmacological approach may be considered as an adjunct strategy for migraine management. →

    Clinical Trials
  • How B2B sales teams reduce admin time from 5 hours to 30 minutes daily with unified CRM data

    7 октября, 2025

    Salespeople spend nearly 70% of their week caught up in the whirlwind of administrative tasks. Only 30% of their time actually goes to selling. Reps are drowning in spreadsheets and melting in admin tasks that assistants could handle. Unified CRM data systems can help. These integrated technology platforms consolidate customer-related information from multiple sources into… →

    AI Sales
    AI, Analytics, B2BMarketing, B2BSales, BrandStrategy, ContentMarketing, ConversionOptimization, CustomerExperience, DataDriven, DigitalMarketing, Ecommerce, GrowthHacking, InboundMarketing, LeadGeneration, MarketingAutomation, MarketingTips, Salesforce, SEO, SocialSelling, TechnologyTrends
  • Comparison of effect of massage or chicory bath on bilirubin levels in term newborns undergoing phototherapy: a randomized clinical trial

    7 октября, 2025

    CONCLUSION: Based on the results of the present study, Field massage combined with phototherapy was more effective in increasing the frequency of defecation and reducing the length of hospitalization in infants with hyperbilirubinemia compared to those in the chicory bath group and the control group who received phototherapy only. →

    Clinical Trials
  • Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses

    7 октября, 2025

    In the primary analysis (32.3-month median follow-up) of the randomized, phase 3 AURIGA study (NCT03901963), daratumumab-lenalidomide (D-R) maintenance significantly improved MRD-negative conversion rates and reduced the risk of disease progression or death by 47% versus R maintenance in anti-CD38 monoclonal antibody-naïve and post-transplant MRD-positive patients with newly diagnosed MM. Here, we present a post hoc… →

    Clinical Trials
  • Non-invasive high frequency oscillatory ventilation for primary respiratory support in extremely preterm infants: multicentre randomised controlled trial

    7 октября, 2025

    CONCLUSIONS: NHFOV appeared superior to NCPAP in reducing the need for intubation when used as a primary respiratory support strategy in extremely preterm infants. Both techniques did not show significant differences in neonatal adverse events. →

    Clinical Trials
  • Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide

    7 октября, 2025

    CONCLUSIONS: This subgroup analysis of patients who received CYC shows similar rates of remission in the avacopan and prednisone taper groups. Compared with the prednisone taper regimen, the avacopan regimen was associated with a numerically lower relapse rate, greater improvement in eGFR, faster reduction in UACR, lower glucocorticoid-related toxicity and similar overall safety. These results… →

    Clinical Trials
  • Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trial

    7 октября, 2025

    CONCLUSION: Our findings establish a connection between type I interferon signalling, pyrimidine metabolism and uremic toxins in patients with LN and support the evaluation of urine uracil as a potential biomarker of response to anifrolumab. →

    Clinical Trials
  • Google DeepMind Introduces CodeMender: A New AI Agent that Uses Gemini Deep Think to Automatically Patch Critical Software Vulnerabilities

    7 октября, 2025

    «`html Google DeepMind Introduces CodeMender: An AI Agent for Automated Software Vulnerability Patching Understanding the Target Audience The target audience for CodeMender primarily includes software developers, security professionals, and IT managers. Their pain points involve the increasing complexity of codebases and the growing number of vulnerabilities that need to be patched quickly and efficiently. They… →

    AI News
  • Building a Human Handoff Interface for AI-Powered Insurance Agent Using Parlant and Streamlit

    7 октября, 2025

    «`html Building a Human Handoff Interface for AI-Powered Insurance Agent Using Parlant and Streamlit Human handoff is a key component of customer service automation—it ensures that when AI reaches its limits, a skilled human can seamlessly take over. In this tutorial, we’ll implement a human handoff system for an AI-powered insurance agent using Parlant. You’ll… →

    AI News
  • Business Model Innovation: Seven Essentials

    7 октября, 2025

    Matt Harrison Clough / Ikon Images In an age where innovation reigns supreme, it’s easy for leaders to believe that a novel business model equals a ticket to success. The logic is appealing: Be the first to offer something new, or something familiar in a new way, and the profits will follow. This idea becomes… →

    Management
Предыдущая страница
1 … 165 166 167 168 169 … 975
Следующая страница